VFIC
FENC icon

Valley Forge Investment Consultants’s Fennec Pharmaceuticals FENC Stock Holding History

Valley Forge Investment Consultants’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-40,000
Closed -$324K – 79
2022
Q3 		$324K Hold
40,000
– – 0.18% 50
2022
Q2 		$223K Hold
40,000
– – 0.11% 63
2022
Q1 		$224K Hold
40,000
– – 0.09% 71
2021
Q4 		$176K Hold
40,000
– – 0.08% 71
2021
Q3 		$377K Hold
40,000
– – 0.2% 47
2021
Q2 		$292K Hold
40,000
– – 0.16% 58
2021
Q1 		$248K Hold
40,000
– – 0.17% 58
2020
Q4 		$298K Buy
+40,000
New +$305K 0.26% 46

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Valley Forge Investment Consultants's FENC Position: Q4 2022 in Review

Valley Forge Investment Consultants sold out of Fennec Pharmaceuticals (FENC) in Q4 2022, closing a stake of 40,000 shares — an estimated $324K sold.

Valley Forge Investment Consultants first reported a position in FENC in Q4 2020 and held it in 8 quarters. The position peaked at $377K in Q3 2021. 43 funds tracked by Wall St. Rank hold FENC as of Q4 2022.

  • Valley Forge Investment Consultants reported no remaining Fennec Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Valley Forge Investment Consultants sold 40,000 Fennec Pharmaceuticals shares in Q4 2022, an estimated $324K.
  • Valley Forge Investment Consultants first reported a position in Fennec Pharmaceuticals in Q4 2020 and held it in 8 quarters.
  • Valley Forge Investment Consultants's Fennec Pharmaceuticals position peaked at $377K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2022.

Based on Valley Forge Investment Consultants's 13F filing for Q4 2022, filed 14 Feb 2023.